Ascendia

  MARKET NEWS

Curia Appoints New Vice President, Biologics
MAIA Biotechnology Completes Enrollment in Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
Tarsus Announces Positive Topline Results From Phase 2a Proof-of-Concept Trial Evaluating TP-05 for the Prevention of Lyme Disease
Aptar Digital Health Announces Acquisition of Healint to Reinforce Digital Health Portfolio & Drive Future Growth
Polpharma Biologics’ Investigational Biosimilar Shows PK/PD Comparability to Inflammatory Bowel Disease Blockbuster Entyvio
Avenue Therapeutics Announces First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

  FEATURED EDITORIAL

  COMPANY PROFILE

Roquette Pharma Solutions offers a large and diverse portfolio of reliable, plant-based excipients, nutraceutical active ingredients, active pharmaceutical ingredients, high-quality and multi-compendial specialty ingredients, and pyrogen-free carbohydrates. Our Pharmaceutical Innovation Center in the US is dedicated to advancing the research of drug delivery systems for oral prescription drugs while improving speed to market. It complements the advanced biopharmaceutical research conducted at our Singapore Innovation Center, as well as our central R&D facility in France. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Jubilant HollisterStier Opens Third Manufacturing Line

Jubilant HollisterStier Opens Third Manufacturing Line

Jubilant HollisterStier recently celebrated the opening of its third sterile fill finish manufacturing line and broke ground on the next phase of its facility expansion in Spokane, WA…..

Cresset Announces Global Collaboration With Enamine on New Virtual Screening Drug Discovery Technology

Cresset Announces Global Collaboration With Enamine on New Virtual Screening Drug Discovery Technology

Cresset recently announced a collaboration with Enamine, the world’s leading provider of chemical building blocks and drug discovery services to develop innovative….

Eton Pharmaceuticals Awarded US Patent for Proprietary Hydrocortisone Oral Liquid Formulation

Eton Pharmaceuticals Awarded US Patent for Proprietary Hydrocortisone Oral Liquid Formulation

Eton Pharmaceuticals recently announced the United States Patent and Trademark Office (USPTO) has granted the company’s US Patent Application No. 18/113,458, which covers the….

XOMA Enters Agreement to Acquire Kinnate Biopharma

XOMA Enters Agreement to Acquire Kinnate Biopharma

Upon closing, XOMA anticipates adding approximately $9.5 million in cash to its balance sheet and several early-stage programs to potentially add to its royalty portfolio….

Evonik Partners With University of Mainz to Commercialize New Class of PEG Lipids for Nucleic Acid Delivery

Evonik Partners With University of Mainz to Commercialize New Class of PEG Lipids for Nucleic Acid Delivery

Evonik and the University of Mainz have signed a license agreement to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs. Evonik intends to use….

  WHITEPAPERS & WEBINARS

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

WEBINAR - 2024 Trends in Topical Drug Delivery: Insights & Innovation

This webinar will discuss some of the key trends from these leaders in the topical market on both a global and regional level, including the increased importance of sensory properties and the rise in non-conventional product formats, among others…..

WEBINAR - Enabling Upstream Intensified Bioprocessing

WEBINAR - Enabling Upstream Intensified Bioprocessing

Intensified upstream bioprocesses are being developed to increase productivity while reducing footprint, costs, and timelines for manufacturing. The higher cell densities generated by….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

While large molecules continue to advance in drug development pipelines, small molecule Active Pharmaceutical Ingredients (APIs) still retain their historical dominance among new drug applications (NDAs). However, the last few years have seen the lines blurring between traditional chemical synthesis …

WHITEPAPER - Minimizing API Supply Chain Risks

WHITEPAPER - Minimizing API Supply Chain Risks

By the time your API is brought to a contract manufacturing organization (CMO), you have already put extensive amounts of resources into developing it. It becomes essential that you optimize your API supply chain to be aware of potential risks

…

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

WHITEPAPER: Innovating Pharma Barrier Packaging for a Sustainable Future

Honeywell Aclar® thermoformable film enables pharmaceutical and medical device companies to achieve their sustainability commitments.

Aclar® film not only delivers a high moisture barrier to protect medicines, but it also reduces pack size, reduces waste, and reduces carbon emissions, compared

…

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

March 6 – Parenteral Contract Manufacturing
March 13 – Polymers & Biomaterials